Prospective association between emotional health and clinical evidence of Parkinson's disease

European Journal of Neurology

Volumn 15, Issue 11, 2008, Pages 1148-1154

  Ishihara Paul, L ^a   Wainwright, N W J ^a   Khaw, K T ^b   Luben, R N ^a   Welch, A A ^a   Day, N E ^a   Brayne, C ^a   Surtees, P G ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Anxiety; Depression; Neuroticism; Parkinson's disease; Prospective

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; COMORBIDITY; DEATH CERTIFICATE; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG USE; EMOTIONAL STABILITY; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL ASSISTANT; NEUROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SELF REPORT;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; DISABILITY EVALUATION; FEMALE; GREAT BRITAIN; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; MENTAL HEALTH; MIDDLE AGED; MOOD DISORDERS; PARKINSON DISEASE; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SOCIAL CLASS;

EID: 53549115074     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02299.x     Document Type: Article

References (32)

1. Richard IH. Anxiety disorders in Parkinson's disease. Advances in Neurology 2005 96 : 42 55.
2. Lieberman A. Depression in Parkinson's disease - a review. Acta Neurologica Scandinavica 2006 113 : 1 8.
3. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease - a community-based study. Archives of Neurology 1996 53 : 175 179.
4. Ravina B, Camicioli R, Como PG, et al. The impact of depressive symptoms in early Parkinson disease. Neurology 2007 69 : 342 347.
5. Poewe W. Non-motor symptoms in Parkinson's disease. European Journal of Neurology 2008 15 (Suppl. 1 14 20.
6. Lemke MR. Depressive symptoms in Parkinson's disease. European Journal of Neurology 2008 15 (Suppl. 1 21 25.
7. Ishihara L, Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Movement Disorders 2006 21 : 1066 1072.
8. Paulson GW, Dadmehr N. Is there a premorbid personality typical for Parkinson's disease. Neurology 1991 41 : 73 76.
9. Jiménez-Jiménez FJ, Santos J, Zancada F, et al. "Premorbid" personality of patients with Parkinson's disease. Acta Neurologica (Napoli) 1992 14 : 208 214.
10. Heberlein I, Ludin HP, Scholz J, Vieregge P. Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1998 64 : 262 266.
11. Kendler KS, Gatz M, Gardner CO, Pedersen NL. Personality and major depression: a Swedish longitudinal, population-based twin study. Archives of General Psychiatry 2006 63 : 1113 1120.
12. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. British Journal of Cancer 1999 80 (Suppl. 1 95 103.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC : American Psychiatric Association (APA), 1994.
14. Surtees PG, Wainwright NWJ, Brayne C. Psychosocial aetiology of chronic disease: a pragmatic approach to the assessment of lifetime affective morbidity in an EPIC component study. Journal of Epidemiology and Community Health 2000 54 : 114 122.
15. Surtees PG, Wainwright NWJ, Khaw K-T, Day NE. Functional health status, chronic medical conditions and disorders of mood. British Journal of Psychiatry 2003 183 : 299 303.
16. Surtees PG, Wainwright NWJ, Luben RN, Wareham NJ, Bingham SA, Khaw KT. Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study. American Journal of Psychiatry 2008 165 : 515 523.
17. Eysenck HJ, Eysenck SBG. Manual of the Eysenck Personality Inventory. London : University of London Press, 1964.
18. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA : Nimrod Press, 1993.
19. Rogers WH, Adler DA, Bungay KM, Wilson IB. Depression screening instruments made good severity measures in a cross-sectional analysis. Journal of Clinical Epidemiology 2005 58 : 370 377.
20. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006 66 : 968 975.
21. de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology 2000 54 : S21 S23.
22. von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. European Neuropsychopharmacology 2005 15 : 473 490.
23. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000 123 : 665 676.
24. Brewis M, Poskanzer DC, Rolland C, Miller H. Neurological disease in an English city. Acta Neurologica Scandinavica 1966 42 (Suppl. 24 1 89.
25. Foltynie T, Matthews FE, Ishihara L, Brayne C. The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort. BMC Neurology 2006 (published 22 August 2006) doi :.
26. O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Movement Disorders 2008 23 : 101 106.
27. Weisskopf MG, Chen HL, Schwarzschild MA, Kawachi I, Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Movement Disorders 2003 18 : 646 651.
28. Bernheim H, Birkmaye W, Hornykie O, Jellinge K, Seitelbe F. Brain dopamine and syndromes of Parkinson and Huntington - clinical, morphological and neurochemical correlations. Journal of the Neurological Sciences 1973 20 : 415 455.
29. Agid Y, Ahlskog E, Albanese A, et al. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Movement Disorders 1999 14 : 911 913.
30. Lemke MR, Fuchs G, Gemende I, et al. Depression and Parkinson's disease. Journal of Neurology 2004 251 : 24 27.
31. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry 2007 64 : 327 337.
32. Post B, Merkus MP, de Haan RJ, Speelman JD, CARPA Study Group. Prognostic factors for the progression of Parkinson's disease: a systematic review. Movement Disorders 2007 22 : 1839 1851.